EnGeneIC
EngeneIC is a biopharmaceutical company focused on developing its proprietary EDV™ nanocell platform for the targeted delivery of chemotherapeutics and functional nucleic acids in cancer. The EDV™ is a first-in-class Cyto-Immunotherapy platform.
EnGeneIC Offices
OnSite Workspace
Employees work from physical offices.
Typical time on-site:
None
Sydney, New South Wales, AU
